RNS Number : 3041T
Minoan Group PLC
14 November 2023
 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

14 November 2023

Minoan Group Plc
(the "Company" or "Minoan")

Issue of Shares

At the Company's General Meeting held on 10 November 2023, Resolution 1 seeking authorisation to settle £707,231 of the Loan outstanding to DAGG LLP by the issue of shares, was duly passed.

 

Following this shareholder approval, the Directors of Minoan announce the issue of 70,723,100 Ordinary Shares of 1p each ("Ordinary Shares") at the price 1p per Ordinary Share.

 

Application has been made for the total of 70,723,100 new Ordinary Shares to be admitted to trading on AIM ("Admission") and it is expected that Admission will be effective from 15 November 2023. Following Admission, there will be a total of 822,091,319 Ordinary Shares in issue. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Minoan under the FCA's Disclosure Guidance and Transparency Rules.

 

 

For further information visit www.minoangroup.com or contact:

 

Minoan Group Plc

Christopher Egleton                                        christopher.egleton@minoangroup.com

George Mergos                                               georgios.mergos@minoangroup.com

 

W H Ireland Limited                                       020 7220 1666
Antonio Bossi                                      

 

Peterhouse Capital Limited                            020 7469 0930

Duncan Vasey                                                              

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEUOURROWUAAUA